{
    "2018-03-27": [
        [
            {
                "time": "",
                "original_text": "[推荐评级]医药行业周报：三把“火”有望催化医药“大年”",
                "features": {
                    "keywords": [
                        "医药行业",
                        "周报",
                        "三把火",
                        "催化",
                        "大年"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "[买入评级]医药生物行业投资策略：部委调整 明确医保医疗医药三方职责",
                "features": {
                    "keywords": [
                        "买入评级",
                        "医药生物",
                        "投资策略",
                        "部委调整",
                        "医保医疗医药"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "[强烈推荐评级]丽珠集团(000513)年报点评：业绩符合预期 基层销售逐步发力 华丽转型创新生物药前景光明",
                "features": {
                    "keywords": [
                        "丽珠集团",
                        "年报点评",
                        "业绩",
                        "基层销售",
                        "转型",
                        "创新生物药",
                        "前景光明"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业周报: 关注医药板块防御性机会",
                "features": {
                    "keywords": [
                        "医药生物",
                        "周报",
                        "防御性机会"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}